nodes	percent_of_prediction	percent_of_DWPC	metapath
Mercaptopurine—Adenine—Azathioprine—multiple sclerosis	0.454	1	CrCrCtD
Mercaptopurine—HPRT1—Azathioprine—multiple sclerosis	0.17	0.385	CbGbCtD
Mercaptopurine—SLC28A3—Cladribine—multiple sclerosis	0.105	0.238	CbGbCtD
Mercaptopurine—TPMT—Azathioprine—multiple sclerosis	0.0978	0.221	CbGbCtD
Mercaptopurine—XDH—Azathioprine—multiple sclerosis	0.0406	0.0919	CbGbCtD
Mercaptopurine—AOX1—Methotrexate—multiple sclerosis	0.0154	0.0348	CbGbCtD
Mercaptopurine—Hepatosplenic T-cell lymphoma—Azathioprine—multiple sclerosis	0.00969	0.166	CcSEcCtD
Mercaptopurine—ABCC4—Methotrexate—multiple sclerosis	0.0078	0.0177	CbGbCtD
Mercaptopurine—SLC22A8—Methotrexate—multiple sclerosis	0.00487	0.011	CbGbCtD
Mercaptopurine—HPRT1—Nucleotide Metabolism—SRM—multiple sclerosis	0.00404	0.153	CbGpPWpGaD
Mercaptopurine—Inflammatory bowel disease—Azathioprine—multiple sclerosis	0.00343	0.0586	CcSEcCtD
Mercaptopurine—HPRT1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00216	0.0816	CbGpPWpGaD
Mercaptopurine—PPAT—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00139	0.0525	CbGpPWpGaD
Mercaptopurine—Malabsorption—Methotrexate—multiple sclerosis	0.00129	0.022	CcSEcCtD
Mercaptopurine—Myelosuppression—Cladribine—multiple sclerosis	0.00122	0.0208	CcSEcCtD
Mercaptopurine—Liver injury—Fingolimod—multiple sclerosis	0.0012	0.0204	CcSEcCtD
Mercaptopurine—PPAT—retina—multiple sclerosis	0.001	0.057	CbGeAlD
Mercaptopurine—Myelosuppression—Azathioprine—multiple sclerosis	0.000989	0.0169	CcSEcCtD
Mercaptopurine—Polyp—Cladribine—multiple sclerosis	0.000937	0.016	CcSEcCtD
Mercaptopurine—Oral candidiasis—Cladribine—multiple sclerosis	0.000898	0.0153	CcSEcCtD
Mercaptopurine—Oligospermia—Methotrexate—multiple sclerosis	0.000891	0.0152	CcSEcCtD
Mercaptopurine—SLC29A1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000857	0.0324	CbGpPWpGaD
Mercaptopurine—Cyst—Cladribine—multiple sclerosis	0.000853	0.0146	CcSEcCtD
Mercaptopurine—Myelosuppression—Mitoxantrone—multiple sclerosis	0.000799	0.0137	CcSEcCtD
Mercaptopurine—HPRT1—retina—multiple sclerosis	0.000768	0.0437	CbGeAlD
Mercaptopurine—Polyp—Azathioprine—multiple sclerosis	0.000762	0.013	CcSEcCtD
Mercaptopurine—PPAT—medulla oblongata—multiple sclerosis	0.000724	0.0412	CbGeAlD
Mercaptopurine—PPAT—Nucleotide metabolism—RRM1—multiple sclerosis	0.000697	0.0264	CbGpPWpGaD
Mercaptopurine—HPRT1—Nucleotide metabolism—RRM1—multiple sclerosis	0.000697	0.0264	CbGpPWpGaD
Mercaptopurine—Cyst—Azathioprine—multiple sclerosis	0.000694	0.0119	CcSEcCtD
Mercaptopurine—Azoospermia—Methotrexate—multiple sclerosis	0.000693	0.0119	CcSEcCtD
Mercaptopurine—Bone marrow depression—Azathioprine—multiple sclerosis	0.000687	0.0117	CcSEcCtD
Mercaptopurine—PPAT—midbrain—multiple sclerosis	0.000661	0.0376	CbGeAlD
Mercaptopurine—TPMT—retina—multiple sclerosis	0.000648	0.0369	CbGeAlD
Mercaptopurine—PPAT—spinal cord—multiple sclerosis	0.000645	0.0367	CbGeAlD
Mercaptopurine—SLC28A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000641	0.0242	CbGpPWpGaD
Mercaptopurine—Hyperuricaemia—Cladribine—multiple sclerosis	0.000615	0.0105	CcSEcCtD
Mercaptopurine—Cholestasis—Azathioprine—multiple sclerosis	0.00061	0.0104	CcSEcCtD
Mercaptopurine—Hepatotoxicity—Azathioprine—multiple sclerosis	0.0006	0.0103	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Cladribine—multiple sclerosis	0.000581	0.00993	CcSEcCtD
Mercaptopurine—SLC28A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000569	0.0215	CbGpPWpGaD
Mercaptopurine—ABCC5—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000568	0.0215	CbGpPWpGaD
Mercaptopurine—ABCC5—retina—multiple sclerosis	0.000562	0.032	CbGeAlD
Mercaptopurine—HPRT1—medulla oblongata—multiple sclerosis	0.000555	0.0316	CbGeAlD
Mercaptopurine—Bone marrow depression—Mitoxantrone—multiple sclerosis	0.000555	0.00949	CcSEcCtD
Mercaptopurine—Liver injury—Azathioprine—multiple sclerosis	0.000551	0.00942	CcSEcCtD
Mercaptopurine—Candida infection—Cladribine—multiple sclerosis	0.000544	0.00931	CcSEcCtD
Mercaptopurine—PPAT—nervous system—multiple sclerosis	0.000544	0.0309	CbGeAlD
Mercaptopurine—SLC29A2—cerebellum—multiple sclerosis	0.000532	0.0302	CbGeAlD
Mercaptopurine—PPAT—central nervous system—multiple sclerosis	0.000524	0.0298	CbGeAlD
Mercaptopurine—Neoplasm—Cladribine—multiple sclerosis	0.000516	0.00881	CcSEcCtD
Mercaptopurine—PPAT—cerebellum—multiple sclerosis	0.000512	0.0291	CbGeAlD
Mercaptopurine—HPRT1—midbrain—multiple sclerosis	0.000508	0.0289	CbGeAlD
Mercaptopurine—HPRT1—spinal cord—multiple sclerosis	0.000495	0.0282	CbGeAlD
Mercaptopurine—Sepsis—Cladribine—multiple sclerosis	0.000495	0.00846	CcSEcCtD
Mercaptopurine—SLC28A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000486	0.0184	CbGpPWpGaD
Mercaptopurine—Skin hyperpigmentation—Triamcinolone—multiple sclerosis	0.000475	0.00813	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Methylprednisolone—multiple sclerosis	0.000474	0.00811	CcSEcCtD
Mercaptopurine—TPMT—medulla oblongata—multiple sclerosis	0.000468	0.0266	CbGeAlD
Mercaptopurine—Hepatocellular injury—Azathioprine—multiple sclerosis	0.000464	0.00793	CcSEcCtD
Mercaptopurine—Alopecia—Fingolimod—multiple sclerosis	0.000446	0.00763	CcSEcCtD
Mercaptopurine—SLC29A2—brain—multiple sclerosis	0.000432	0.0246	CbGeAlD
Mercaptopurine—Skin hyperpigmentation—Betamethasone—multiple sclerosis	0.000431	0.00737	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Dexamethasone—multiple sclerosis	0.000431	0.00737	CcSEcCtD
Mercaptopurine—TPMT—midbrain—multiple sclerosis	0.000428	0.0243	CbGeAlD
Mercaptopurine—Neoplasm—Azathioprine—multiple sclerosis	0.000419	0.00717	CcSEcCtD
Mercaptopurine—TPMT—spinal cord—multiple sclerosis	0.000418	0.0238	CbGeAlD
Mercaptopurine—HPRT1—nervous system—multiple sclerosis	0.000417	0.0237	CbGeAlD
Mercaptopurine—PPAT—brain—multiple sclerosis	0.000416	0.0236	CbGeAlD
Mercaptopurine—ABCC5—medulla oblongata—multiple sclerosis	0.000406	0.0231	CbGeAlD
Mercaptopurine—Hyperuricaemia—Mitoxantrone—multiple sclerosis	0.000404	0.00691	CcSEcCtD
Mercaptopurine—HPRT1—central nervous system—multiple sclerosis	0.000402	0.0229	CbGeAlD
Mercaptopurine—Ulcer—Mitoxantrone—multiple sclerosis	0.000396	0.00677	CcSEcCtD
Mercaptopurine—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000394	0.0149	CbGpPWpGaD
Mercaptopurine—Leukopenia—Fingolimod—multiple sclerosis	0.000394	0.00673	CcSEcCtD
Mercaptopurine—HPRT1—cerebellum—multiple sclerosis	0.000393	0.0223	CbGeAlD
Mercaptopurine—Blood uric acid increased—Mitoxantrone—multiple sclerosis	0.000382	0.00652	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.000372	0.00636	CcSEcCtD
Mercaptopurine—ABCC5—midbrain—multiple sclerosis	0.000371	0.0211	CbGeAlD
Mercaptopurine—TPMT—nervous system—multiple sclerosis	0.000352	0.02	CbGeAlD
Mercaptopurine—Skin disorder—Fingolimod—multiple sclerosis	0.000349	0.00596	CcSEcCtD
Mercaptopurine—TPMT—Biological oxidations—CYP24A1—multiple sclerosis	0.000344	0.013	CbGpPWpGaD
Mercaptopurine—TPMT—Biological oxidations—CYP27B1—multiple sclerosis	0.000344	0.013	CbGpPWpGaD
Mercaptopurine—Pancytopenia—Cladribine—multiple sclerosis	0.00034	0.00581	CcSEcCtD
Mercaptopurine—TPMT—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00034	0.0128	CbGpPWpGaD
Mercaptopurine—TPMT—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00034	0.0128	CbGpPWpGaD
Mercaptopurine—SLC28A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000339	0.0128	CbGpPWpGaD
Mercaptopurine—TPMT—central nervous system—multiple sclerosis	0.000339	0.0193	CbGeAlD
Mercaptopurine—SLC29A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000337	0.0127	CbGpPWpGaD
Mercaptopurine—TPMT—cerebellum—multiple sclerosis	0.000331	0.0188	CbGeAlD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000326	0.0123	CbGpPWpGaD
Mercaptopurine—Sepsis—Mitoxantrone—multiple sclerosis	0.000325	0.00556	CcSEcCtD
Mercaptopurine—HPRT1—brain—multiple sclerosis	0.000319	0.0181	CbGeAlD
Mercaptopurine—Skin hyperpigmentation—Methotrexate—multiple sclerosis	0.000314	0.00537	CcSEcCtD
Mercaptopurine—SLC28A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000313	0.0118	CbGpPWpGaD
Mercaptopurine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00031	0.0053	CcSEcCtD
Mercaptopurine—Polyp—Methotrexate—multiple sclerosis	0.000307	0.00525	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Cladribine—multiple sclerosis	0.000302	0.00516	CcSEcCtD
Mercaptopurine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000299	0.0113	CbGpPWpGaD
Mercaptopurine—Ulcer—Triamcinolone—multiple sclerosis	0.000299	0.00511	CcSEcCtD
Mercaptopurine—XDH—Nucleotide metabolism—RRM1—multiple sclerosis	0.000298	0.0113	CbGpPWpGaD
Mercaptopurine—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000289	0.0109	CbGpPWpGaD
Mercaptopurine—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.000288	0.0109	CbGpPWpGaD
Mercaptopurine—ABCC5—cerebellum—multiple sclerosis	0.000287	0.0163	CbGeAlD
Mercaptopurine—HPRT1—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.000285	0.207	CbGdCrCtD
Mercaptopurine—Pancreatitis—Azathioprine—multiple sclerosis	0.000285	0.00488	CcSEcCtD
Mercaptopurine—HPRT1—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.000281	0.204	CbGdCrCtD
Mercaptopurine—HPRT1—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.000281	0.204	CbGdCrCtD
Mercaptopurine—SLC29A1—nervous system—multiple sclerosis	0.00028	0.0159	CbGeAlD
Mercaptopurine—Cyst—Methotrexate—multiple sclerosis	0.000279	0.00478	CcSEcCtD
Mercaptopurine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000278	0.0105	CbGpPWpGaD
Mercaptopurine—Bone marrow depression—Methotrexate—multiple sclerosis	0.000277	0.00473	CcSEcCtD
Mercaptopurine—Pancytopenia—Azathioprine—multiple sclerosis	0.000276	0.00472	CcSEcCtD
Mercaptopurine—HPRT1—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.000274	0.199	CbGdCrCtD
Mercaptopurine—Ulcer—Betamethasone—multiple sclerosis	0.000271	0.00464	CcSEcCtD
Mercaptopurine—Ulcer—Dexamethasone—multiple sclerosis	0.000271	0.00464	CcSEcCtD
Mercaptopurine—Candida infection—Triamcinolone—multiple sclerosis	0.00027	0.00462	CcSEcCtD
Mercaptopurine—SLC29A1—central nervous system—multiple sclerosis	0.00027	0.0153	CbGeAlD
Mercaptopurine—TPMT—brain—multiple sclerosis	0.000269	0.0153	CbGeAlD
Mercaptopurine—SLC29A1—cerebellum—multiple sclerosis	0.000264	0.015	CbGeAlD
Mercaptopurine—Immune system disorder—Cladribine—multiple sclerosis	0.000259	0.00442	CcSEcCtD
Mercaptopurine—SLC29A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000255	0.00965	CbGpPWpGaD
Mercaptopurine—HPRT1—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.000254	0.185	CbGdCrCtD
Mercaptopurine—Alopecia—Cladribine—multiple sclerosis	0.000253	0.00433	CcSEcCtD
Mercaptopurine—Malnutrition—Cladribine—multiple sclerosis	0.000249	0.00426	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000247	0.00934	CbGpPWpGaD
Mercaptopurine—AOX1—cerebellum—multiple sclerosis	0.000246	0.014	CbGeAlD
Mercaptopurine—ABCC5—Defective B3GAT3 causes JDSSDHD—GPC5—multiple sclerosis	0.000246	0.00929	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Fingolimod—multiple sclerosis	0.000246	0.0042	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.000245	0.00419	CcSEcCtD
Mercaptopurine—Hepatotoxicity—Methotrexate—multiple sclerosis	0.000242	0.00413	CcSEcCtD
Mercaptopurine—SLC28A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000237	0.00897	CbGpPWpGaD
Mercaptopurine—Ulcer—Prednisone—multiple sclerosis	0.000236	0.00404	CcSEcCtD
Mercaptopurine—SLC29A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000233	0.00883	CbGpPWpGaD
Mercaptopurine—ABCC5—brain—multiple sclerosis	0.000233	0.0133	CbGeAlD
Mercaptopurine—Anaemia—Cladribine—multiple sclerosis	0.00023	0.00394	CcSEcCtD
Mercaptopurine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000223	0.00382	CcSEcCtD
Mercaptopurine—SLC29A1—brain—multiple sclerosis	0.000214	0.0122	CbGeAlD
Mercaptopurine—Arthralgia—Cladribine—multiple sclerosis	0.000212	0.00363	CcSEcCtD
Mercaptopurine—ABCC4—nervous system—multiple sclerosis	0.000211	0.012	CbGeAlD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000211	0.0036	CcSEcCtD
Mercaptopurine—Immune system disorder—Azathioprine—multiple sclerosis	0.00021	0.0036	CcSEcCtD
Mercaptopurine—SLC22A8—nervous system—multiple sclerosis	0.00021	0.0119	CbGeAlD
Mercaptopurine—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.000209	0.00789	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000207	0.00784	CbGpPWpGaD
Mercaptopurine—Alopecia—Azathioprine—multiple sclerosis	0.000206	0.00352	CcSEcCtD
Mercaptopurine—Stomatitis—Mitoxantrone—multiple sclerosis	0.000204	0.00349	CcSEcCtD
Mercaptopurine—ABCC4—central nervous system—multiple sclerosis	0.000204	0.0116	CbGeAlD
Mercaptopurine—Oedema—Cladribine—multiple sclerosis	0.000203	0.00348	CcSEcCtD
Mercaptopurine—SLC22A8—central nervous system—multiple sclerosis	0.000202	0.0115	CbGeAlD
Mercaptopurine—Hyperuricaemia—Methotrexate—multiple sclerosis	0.000201	0.00344	CcSEcCtD
Mercaptopurine—AOX1—brain—multiple sclerosis	0.0002	0.0114	CbGeAlD
Mercaptopurine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000199	0.00341	CcSEcCtD
Mercaptopurine—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000199	0.00751	CbGpPWpGaD
Mercaptopurine—Skin disorder—Cladribine—multiple sclerosis	0.000198	0.00338	CcSEcCtD
Mercaptopurine—Ulcer—Methotrexate—multiple sclerosis	0.000197	0.00338	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000195	0.00738	CbGpPWpGaD
Mercaptopurine—Anorexia—Cladribine—multiple sclerosis	0.000194	0.00332	CcSEcCtD
Mercaptopurine—Sepsis—Prednisone—multiple sclerosis	0.000194	0.00331	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Methotrexate—multiple sclerosis	0.00019	0.00325	CcSEcCtD
Mercaptopurine—Pancreatitis—Prednisolone—multiple sclerosis	0.000189	0.00323	CcSEcCtD
Mercaptopurine—Anaemia—Azathioprine—multiple sclerosis	0.000187	0.0032	CcSEcCtD
Mercaptopurine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000186	0.00705	CbGpPWpGaD
Mercaptopurine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000185	0.00317	CcSEcCtD
Mercaptopurine—Breast disorder—Methylprednisolone—multiple sclerosis	0.000185	0.00316	CcSEcCtD
Mercaptopurine—Leukopenia—Azathioprine—multiple sclerosis	0.000181	0.0031	CcSEcCtD
Mercaptopurine—SLC29A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000178	0.00674	CbGpPWpGaD
Mercaptopurine—SLC29A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000177	0.00669	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Cladribine—multiple sclerosis	0.000177	0.00302	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000176	0.003	CcSEcCtD
Mercaptopurine—Pancreatitis—Triamcinolone—multiple sclerosis	0.000174	0.00297	CcSEcCtD
Mercaptopurine—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000174	0.00297	CcSEcCtD
Mercaptopurine—Arthralgia—Azathioprine—multiple sclerosis	0.000173	0.00295	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000173	0.00652	CbGpPWpGaD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000171	0.00293	CcSEcCtD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000171	0.00647	CbGpPWpGaD
Mercaptopurine—Mouth ulceration—Methotrexate—multiple sclerosis	0.000169	0.00289	CcSEcCtD
Mercaptopurine—Neoplasm—Methotrexate—multiple sclerosis	0.000169	0.00289	CcSEcCtD
Mercaptopurine—Alopecia—Mitoxantrone—multiple sclerosis	0.000166	0.00284	CcSEcCtD
Mercaptopurine—SLC28A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000166	0.00627	CbGpPWpGaD
Mercaptopurine—Sepsis—Methotrexate—multiple sclerosis	0.000162	0.00277	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000162	0.00277	CcSEcCtD
Mercaptopurine—ABCC4—brain—multiple sclerosis	0.000162	0.00919	CbGeAlD
Mercaptopurine—Body temperature increased—Cladribine—multiple sclerosis	0.000161	0.00275	CcSEcCtD
Mercaptopurine—Skin disorder—Azathioprine—multiple sclerosis	0.000161	0.00275	CcSEcCtD
Mercaptopurine—SLC22A8—brain—multiple sclerosis	0.00016	0.00912	CbGeAlD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000159	0.00602	CbGpPWpGaD
Mercaptopurine—Anaemia—Mitoxantrone—multiple sclerosis	0.000151	0.00259	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000151	0.00258	CcSEcCtD
Mercaptopurine—Hypersensitivity—Cladribine—multiple sclerosis	0.00015	0.00256	CcSEcCtD
Mercaptopurine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000147	0.00251	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000143	0.00244	CcSEcCtD
Mercaptopurine—Arthralgia—Mitoxantrone—multiple sclerosis	0.000139	0.00238	CcSEcCtD
Mercaptopurine—Diarrhoea—Cladribine—multiple sclerosis	0.000139	0.00238	CcSEcCtD
Mercaptopurine—Pancreatitis—Prednisone—multiple sclerosis	0.000137	0.00235	CcSEcCtD
Mercaptopurine—Oedema—Mitoxantrone—multiple sclerosis	0.000134	0.00229	CcSEcCtD
Mercaptopurine—ABCC5—Carbohydrate metabolism—GPC5—multiple sclerosis	0.000132	0.00499	CbGpPWpGaD
Mercaptopurine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000131	0.00224	CcSEcCtD
Mercaptopurine—Body temperature increased—Azathioprine—multiple sclerosis	0.000131	0.00224	CcSEcCtD
Mercaptopurine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00013	0.00493	CbGpPWpGaD
Mercaptopurine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00013	0.00222	CcSEcCtD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00013	0.00491	CbGpPWpGaD
Mercaptopurine—Vomiting—Cladribine—multiple sclerosis	0.000129	0.00221	CcSEcCtD
Mercaptopurine—Rash—Cladribine—multiple sclerosis	0.000128	0.00219	CcSEcCtD
Mercaptopurine—Dermatitis—Cladribine—multiple sclerosis	0.000128	0.00219	CcSEcCtD
Mercaptopurine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000128	0.00219	CcSEcCtD
Mercaptopurine—Anorexia—Mitoxantrone—multiple sclerosis	0.000127	0.00218	CcSEcCtD
Mercaptopurine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000124	0.00468	CbGpPWpGaD
Mercaptopurine—Malnutrition—Methylprednisolone—multiple sclerosis	0.000123	0.00211	CcSEcCtD
Mercaptopurine—Breast disorder—Methotrexate—multiple sclerosis	0.000122	0.00209	CcSEcCtD
Mercaptopurine—SLC28A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000122	0.00462	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000122	0.00208	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000122	0.00208	CcSEcCtD
Mercaptopurine—Nausea—Cladribine—multiple sclerosis	0.000121	0.00207	CcSEcCtD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000121	0.00456	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—SRM—multiple sclerosis	0.000119	0.00449	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—SRM—multiple sclerosis	0.000119	0.00449	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000119	0.00449	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000116	0.00199	CcSEcCtD
Mercaptopurine—Pancreatitis—Methotrexate—multiple sclerosis	0.000115	0.00196	CcSEcCtD
Mercaptopurine—Alopecia—Dexamethasone—multiple sclerosis	0.000114	0.00195	CcSEcCtD
Mercaptopurine—Alopecia—Betamethasone—multiple sclerosis	0.000114	0.00195	CcSEcCtD
Mercaptopurine—Diarrhoea—Azathioprine—multiple sclerosis	0.000113	0.00193	CcSEcCtD
Mercaptopurine—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000112	0.00423	CbGpPWpGaD
Mercaptopurine—Pancytopenia—Methotrexate—multiple sclerosis	0.000111	0.0019	CcSEcCtD
Mercaptopurine—Oedema—Prednisolone—multiple sclerosis	0.00011	0.00188	CcSEcCtD
Mercaptopurine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000106	0.00181	CcSEcCtD
Mercaptopurine—Vomiting—Azathioprine—multiple sclerosis	0.000105	0.0018	CcSEcCtD
Mercaptopurine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000105	0.0018	CcSEcCtD
Mercaptopurine—Rash—Azathioprine—multiple sclerosis	0.000104	0.00178	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000104	0.00178	CcSEcCtD
Mercaptopurine—Dermatitis—Azathioprine—multiple sclerosis	0.000104	0.00178	CcSEcCtD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000103	0.00388	CbGpPWpGaD
Mercaptopurine—Stomatitis—Methotrexate—multiple sclerosis	0.000102	0.00174	CcSEcCtD
Mercaptopurine—Immune system disorder—Prednisone—multiple sclerosis	0.000101	0.00173	CcSEcCtD
Mercaptopurine—Oedema—Triamcinolone—multiple sclerosis	0.000101	0.00172	CcSEcCtD
Mercaptopurine—Alopecia—Prednisone—multiple sclerosis	9.91e-05	0.0017	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Methotrexate—multiple sclerosis	9.88e-05	0.00169	CcSEcCtD
Mercaptopurine—Hypersensitivity—Mitoxantrone—multiple sclerosis	9.85e-05	0.00168	CcSEcCtD
Mercaptopurine—Nausea—Azathioprine—multiple sclerosis	9.82e-05	0.00168	CcSEcCtD
Mercaptopurine—Skin disorder—Methylprednisolone—multiple sclerosis	9.78e-05	0.00167	CcSEcCtD
Mercaptopurine—Malnutrition—Prednisone—multiple sclerosis	9.77e-05	0.00167	CcSEcCtD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.53e-05	0.0036	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	9.25e-05	0.0035	CbGpPWpGaD
Mercaptopurine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	9.19e-05	0.00157	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	9.17e-05	0.00157	CcSEcCtD
Mercaptopurine—Oedema—Betamethasone—multiple sclerosis	9.15e-05	0.00156	CcSEcCtD
Mercaptopurine—Oedema—Dexamethasone—multiple sclerosis	9.15e-05	0.00156	CcSEcCtD
Mercaptopurine—Diarrhoea—Mitoxantrone—multiple sclerosis	9.15e-05	0.00156	CcSEcCtD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.06e-05	0.00343	CbGpPWpGaD
Mercaptopurine—Anaemia—Prednisone—multiple sclerosis	9.03e-05	0.00154	CcSEcCtD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.99e-05	0.0034	CbGpPWpGaD
Mercaptopurine—Thrombocytopenia—Betamethasone—multiple sclerosis	8.96e-05	0.00153	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.96e-05	0.00153	CcSEcCtD
Mercaptopurine—XDH—Selenium Micronutrient Network—ICAM1—multiple sclerosis	8.77e-05	0.00332	CbGpPWpGaD
Mercaptopurine—Anorexia—Betamethasone—multiple sclerosis	8.73e-05	0.00149	CcSEcCtD
Mercaptopurine—Anorexia—Dexamethasone—multiple sclerosis	8.73e-05	0.00149	CcSEcCtD
Mercaptopurine—Vomiting—Mitoxantrone—multiple sclerosis	8.5e-05	0.00145	CcSEcCtD
Mercaptopurine—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.47e-05	0.0032	CbGpPWpGaD
Mercaptopurine—Immune system disorder—Methotrexate—multiple sclerosis	8.47e-05	0.00145	CcSEcCtD
Mercaptopurine—Rash—Mitoxantrone—multiple sclerosis	8.43e-05	0.00144	CcSEcCtD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.43e-05	0.00319	CbGpPWpGaD
Mercaptopurine—Dermatitis—Mitoxantrone—multiple sclerosis	8.42e-05	0.00144	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—SRM—multiple sclerosis	8.36e-05	0.00316	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—CYP24A1—multiple sclerosis	8.36e-05	0.00316	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—CYP27B1—multiple sclerosis	8.36e-05	0.00316	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—CYP24A1—multiple sclerosis	8.36e-05	0.00316	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—CYP27B1—multiple sclerosis	8.36e-05	0.00316	CbGpPWpGaD
Mercaptopurine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	8.34e-05	0.00143	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	8.34e-05	0.00143	CcSEcCtD
Mercaptopurine—Arthralgia—Prednisone—multiple sclerosis	8.32e-05	0.00142	CcSEcCtD
Mercaptopurine—Alopecia—Methotrexate—multiple sclerosis	8.29e-05	0.00142	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	8.26e-05	0.00141	CcSEcCtD
Mercaptopurine—Malnutrition—Methotrexate—multiple sclerosis	8.16e-05	0.0014	CcSEcCtD
Mercaptopurine—Hypersensitivity—Prednisolone—multiple sclerosis	8.08e-05	0.00138	CcSEcCtD
Mercaptopurine—Body temperature increased—Triamcinolone—multiple sclerosis	7.97e-05	0.00136	CcSEcCtD
Mercaptopurine—Oedema—Prednisone—multiple sclerosis	7.97e-05	0.00136	CcSEcCtD
Mercaptopurine—Decreased appetite—Dexamethasone—multiple sclerosis	7.96e-05	0.00136	CcSEcCtD
Mercaptopurine—Decreased appetite—Betamethasone—multiple sclerosis	7.96e-05	0.00136	CcSEcCtD
Mercaptopurine—Nausea—Mitoxantrone—multiple sclerosis	7.94e-05	0.00136	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.9e-05	0.00135	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.9e-05	0.00135	CcSEcCtD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.86e-05	0.00297	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.85e-05	0.00297	CbGpPWpGaD
Mercaptopurine—TPMT—Biological oxidations—POMC—multiple sclerosis	7.75e-05	0.00293	CbGpPWpGaD
Mercaptopurine—Skin disorder—Prednisone—multiple sclerosis	7.74e-05	0.00132	CcSEcCtD
Mercaptopurine—ABCC4—Hemostasis—MERTK—multiple sclerosis	7.72e-05	0.00292	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—CD58—multiple sclerosis	7.72e-05	0.00292	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—SELPLG—multiple sclerosis	7.72e-05	0.00292	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—GPC5—multiple sclerosis	7.65e-05	0.00289	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—GPC5—multiple sclerosis	7.65e-05	0.00289	CbGpPWpGaD
Mercaptopurine—Anorexia—Prednisone—multiple sclerosis	7.6e-05	0.0013	CcSEcCtD
Mercaptopurine—Anaemia—Methotrexate—multiple sclerosis	7.54e-05	0.00129	CcSEcCtD
Mercaptopurine—Hypersensitivity—Triamcinolone—multiple sclerosis	7.43e-05	0.00127	CcSEcCtD
Mercaptopurine—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.42e-05	0.00127	CcSEcCtD
Mercaptopurine—XDH—Selenium Micronutrient Network—ALB—multiple sclerosis	7.32e-05	0.00277	CbGpPWpGaD
Mercaptopurine—Leukopenia—Methotrexate—multiple sclerosis	7.31e-05	0.00125	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.26e-05	0.00124	CcSEcCtD
Mercaptopurine—Body temperature increased—Betamethasone—multiple sclerosis	7.24e-05	0.00124	CcSEcCtD
Mercaptopurine—Body temperature increased—Dexamethasone—multiple sclerosis	7.24e-05	0.00124	CcSEcCtD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.11e-05	0.00269	CbGpPWpGaD
Mercaptopurine—Arthralgia—Methotrexate—multiple sclerosis	6.95e-05	0.00119	CcSEcCtD
Mercaptopurine—Decreased appetite—Prednisone—multiple sclerosis	6.93e-05	0.00118	CcSEcCtD
Mercaptopurine—Rash—Prednisolone—multiple sclerosis	6.92e-05	0.00118	CcSEcCtD
Mercaptopurine—Dermatitis—Prednisolone—multiple sclerosis	6.91e-05	0.00118	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.9e-05	0.00118	CcSEcCtD
Mercaptopurine—Diarrhoea—Methylprednisolone—multiple sclerosis	6.89e-05	0.00118	CcSEcCtD
Mercaptopurine—XDH—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.68e-05	0.00252	CbGpPWpGaD
Mercaptopurine—Thrombocytopenia—Methotrexate—multiple sclerosis	6.52e-05	0.00112	CcSEcCtD
Mercaptopurine—Nausea—Prednisolone—multiple sclerosis	6.52e-05	0.00111	CcSEcCtD
Mercaptopurine—Skin disorder—Methotrexate—multiple sclerosis	6.47e-05	0.00111	CcSEcCtD
Mercaptopurine—SLC29A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.42e-05	0.00243	CbGpPWpGaD
Mercaptopurine—Vomiting—Triamcinolone—multiple sclerosis	6.41e-05	0.0011	CcSEcCtD
Mercaptopurine—Vomiting—Methylprednisolone—multiple sclerosis	6.4e-05	0.00109	CcSEcCtD
Mercaptopurine—Rash—Triamcinolone—multiple sclerosis	6.36e-05	0.00109	CcSEcCtD
Mercaptopurine—Dermatitis—Triamcinolone—multiple sclerosis	6.35e-05	0.00109	CcSEcCtD
Mercaptopurine—Anorexia—Methotrexate—multiple sclerosis	6.35e-05	0.00109	CcSEcCtD
Mercaptopurine—Rash—Methylprednisolone—multiple sclerosis	6.35e-05	0.00109	CcSEcCtD
Mercaptopurine—Dermatitis—Methylprednisolone—multiple sclerosis	6.34e-05	0.00108	CcSEcCtD
Mercaptopurine—PPAT—Metabolism—RRM1—multiple sclerosis	6.34e-05	0.0024	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—RRM1—multiple sclerosis	6.34e-05	0.0024	CbGpPWpGaD
Mercaptopurine—Body temperature increased—Prednisone—multiple sclerosis	6.3e-05	0.00108	CcSEcCtD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.28e-05	0.00238	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Betamethasone—multiple sclerosis	6.26e-05	0.00107	CcSEcCtD
Mercaptopurine—Diarrhoea—Dexamethasone—multiple sclerosis	6.26e-05	0.00107	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.21e-05	0.00235	CbGpPWpGaD
Mercaptopurine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.07e-05	0.00104	CcSEcCtD
Mercaptopurine—Nausea—Triamcinolone—multiple sclerosis	5.99e-05	0.00102	CcSEcCtD
Mercaptopurine—Nausea—Methylprednisolone—multiple sclerosis	5.98e-05	0.00102	CcSEcCtD
Mercaptopurine—SLC28A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.97e-05	0.00226	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.95e-05	0.00225	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.95e-05	0.00225	CbGpPWpGaD
Mercaptopurine—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.92e-05	0.00224	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—CYP27B1—multiple sclerosis	5.89e-05	0.00223	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—CYP24A1—multiple sclerosis	5.89e-05	0.00223	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Prednisone—multiple sclerosis	5.87e-05	0.001	CcSEcCtD
Mercaptopurine—Vomiting—Betamethasone—multiple sclerosis	5.82e-05	0.000995	CcSEcCtD
Mercaptopurine—Vomiting—Dexamethasone—multiple sclerosis	5.82e-05	0.000995	CcSEcCtD
Mercaptopurine—Decreased appetite—Methotrexate—multiple sclerosis	5.79e-05	0.00099	CcSEcCtD
Mercaptopurine—Rash—Dexamethasone—multiple sclerosis	5.77e-05	0.000987	CcSEcCtD
Mercaptopurine—Rash—Betamethasone—multiple sclerosis	5.77e-05	0.000987	CcSEcCtD
Mercaptopurine—Dermatitis—Dexamethasone—multiple sclerosis	5.77e-05	0.000986	CcSEcCtD
Mercaptopurine—Dermatitis—Betamethasone—multiple sclerosis	5.77e-05	0.000986	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.75e-05	0.000983	CcSEcCtD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.68e-05	0.00215	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Prednisone—multiple sclerosis	5.45e-05	0.000932	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—SRM—multiple sclerosis	5.45e-05	0.00206	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.45e-05	0.00206	CbGpPWpGaD
Mercaptopurine—Nausea—Dexamethasone—multiple sclerosis	5.44e-05	0.00093	CcSEcCtD
Mercaptopurine—Nausea—Betamethasone—multiple sclerosis	5.44e-05	0.00093	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—GPC5—multiple sclerosis	5.39e-05	0.00204	CbGpPWpGaD
Mercaptopurine—Body temperature increased—Methotrexate—multiple sclerosis	5.27e-05	0.0009	CcSEcCtD
Mercaptopurine—ABCC4—Platelet degranulation—ALB—multiple sclerosis	5.25e-05	0.00198	CbGpPWpGaD
Mercaptopurine—Vomiting—Prednisone—multiple sclerosis	5.07e-05	0.000866	CcSEcCtD
Mercaptopurine—XDH—Metabolism—SRM—multiple sclerosis	5.07e-05	0.00192	CbGpPWpGaD
Mercaptopurine—Rash—Prednisone—multiple sclerosis	5.03e-05	0.000859	CcSEcCtD
Mercaptopurine—Dermatitis—Prednisone—multiple sclerosis	5.02e-05	0.000858	CcSEcCtD
Mercaptopurine—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	5e-05	0.00189	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Methotrexate—multiple sclerosis	4.91e-05	0.000839	CcSEcCtD
Mercaptopurine—ABCC5—Metabolism—SRM—multiple sclerosis	4.86e-05	0.00184	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PLEK—multiple sclerosis	4.77e-05	0.0018	CbGpPWpGaD
Mercaptopurine—Nausea—Prednisone—multiple sclerosis	4.73e-05	0.000809	CcSEcCtD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.71e-05	0.00178	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Methotrexate—multiple sclerosis	4.56e-05	0.000779	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—RRM1—multiple sclerosis	4.46e-05	0.00169	CbGpPWpGaD
Mercaptopurine—SLC29A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.45e-05	0.00168	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—TNF—multiple sclerosis	4.32e-05	0.00163	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.31e-05	0.00163	CbGpPWpGaD
Mercaptopurine—Vomiting—Methotrexate—multiple sclerosis	4.24e-05	0.000724	CcSEcCtD
Mercaptopurine—Rash—Methotrexate—multiple sclerosis	4.2e-05	0.000718	CcSEcCtD
Mercaptopurine—Dermatitis—Methotrexate—multiple sclerosis	4.2e-05	0.000717	CcSEcCtD
Mercaptopurine—AOX1—Disease—GPC5—multiple sclerosis	4.19e-05	0.00159	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.16e-05	0.00157	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.13e-05	0.00156	CbGpPWpGaD
Mercaptopurine—Nausea—Methotrexate—multiple sclerosis	3.96e-05	0.000677	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—CYP27B1—multiple sclerosis	3.84e-05	0.00145	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CYP24A1—multiple sclerosis	3.84e-05	0.00145	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—GPC5—multiple sclerosis	3.74e-05	0.00141	CbGpPWpGaD
Mercaptopurine—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	3.64e-05	0.00138	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—BCHE—multiple sclerosis	3.64e-05	0.00138	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—BCHE—multiple sclerosis	3.64e-05	0.00138	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP27B1—multiple sclerosis	3.57e-05	0.00135	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP24A1—multiple sclerosis	3.57e-05	0.00135	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GPC5—multiple sclerosis	3.51e-05	0.00133	CbGpPWpGaD
Mercaptopurine—XDH—Selenium Micronutrient Network—IL6—multiple sclerosis	3.49e-05	0.00132	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP24A1—multiple sclerosis	3.42e-05	0.00129	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP27B1—multiple sclerosis	3.42e-05	0.00129	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.4e-05	0.00129	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—SELE—multiple sclerosis	3.36e-05	0.00127	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	3.32e-05	0.00126	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.00123	CbGpPWpGaD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.26e-05	0.00123	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.26e-05	0.00123	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	3.22e-05	0.00122	CbGpPWpGaD
Mercaptopurine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	3.16e-05	0.0012	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GPC5—multiple sclerosis	3.13e-05	0.00118	CbGpPWpGaD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.03e-05	0.00115	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.01e-05	0.00114	CbGpPWpGaD
Mercaptopurine—ABCC5—NRF2 pathway—TGFB1—multiple sclerosis	2.96e-05	0.00112	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—RRM1—multiple sclerosis	2.91e-05	0.0011	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.88e-05	0.00109	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—RPL5—multiple sclerosis	2.73e-05	0.00103	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.00102	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SLC11A1—multiple sclerosis	2.61e-05	0.000987	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—RRM1—multiple sclerosis	2.59e-05	0.000981	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—BCHE—multiple sclerosis	2.56e-05	0.00097	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—RPL5—multiple sclerosis	2.43e-05	0.000919	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—ITGA4—multiple sclerosis	2.43e-05	0.000919	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IFNB1—multiple sclerosis	2.41e-05	0.000912	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	2.33e-05	0.00088	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SLC11A1—multiple sclerosis	2.33e-05	0.00088	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.26e-05	0.000855	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—APOE—multiple sclerosis	2.19e-05	0.000828	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—APOE—multiple sclerosis	2.19e-05	0.000828	CbGpPWpGaD
Mercaptopurine—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	2.15e-05	0.000813	CbGpPWpGaD
Mercaptopurine—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.13e-05	0.000806	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CD28—multiple sclerosis	2.08e-05	0.000789	CbGpPWpGaD
Mercaptopurine—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	2.05e-05	0.000776	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.89e-05	0.000714	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—POMC—multiple sclerosis	1.88e-05	0.000711	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—POMC—multiple sclerosis	1.88e-05	0.000711	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CD28—multiple sclerosis	1.86e-05	0.000703	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—ALB—multiple sclerosis	1.71e-05	0.000648	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—ALB—multiple sclerosis	1.71e-05	0.000648	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—BCHE—multiple sclerosis	1.67e-05	0.000632	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IL2RA—multiple sclerosis	1.66e-05	0.000628	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000587	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—APOE—multiple sclerosis	1.54e-05	0.000583	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.5e-05	0.000567	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000563	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CD86—multiple sclerosis	1.49e-05	0.000563	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.47e-05	0.000557	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.44e-05	0.000546	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CD86—multiple sclerosis	1.33e-05	0.000501	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—POMC—multiple sclerosis	1.33e-05	0.000501	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CCR5—multiple sclerosis	1.32e-05	0.000499	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HLA-A—multiple sclerosis	1.29e-05	0.000486	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ALB—multiple sclerosis	1.21e-05	0.000457	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—APOE—multiple sclerosis	1.2e-05	0.000454	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—ALB—multiple sclerosis	1.2e-05	0.000454	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CCR5—multiple sclerosis	1.18e-05	0.000445	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HLA-A—multiple sclerosis	1.15e-05	0.000433	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CD80—multiple sclerosis	1.09e-05	0.00041	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.08e-05	0.00041	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—APOE—multiple sclerosis	1.07e-05	0.000405	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.04e-05	0.000393	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—APOE—multiple sclerosis	1.01e-05	0.00038	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IL2—multiple sclerosis	9.73e-06	0.000368	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CD80—multiple sclerosis	9.67e-06	0.000366	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—APOE—multiple sclerosis	9.34e-06	0.000353	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TYK2—multiple sclerosis	9.16e-06	0.000346	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—APOE—multiple sclerosis	8.96e-06	0.000339	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—POMC—multiple sclerosis	8.63e-06	0.000327	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CD4—multiple sclerosis	8.28e-06	0.000313	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TYK2—multiple sclerosis	8.16e-06	0.000309	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—POMC—multiple sclerosis	8.03e-06	0.000304	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ALB—multiple sclerosis	7.87e-06	0.000298	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—POMC—multiple sclerosis	7.7e-06	0.000291	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—TGFB1—multiple sclerosis	7.59e-06	0.000287	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—MAPK1—multiple sclerosis	7.44e-06	0.000281	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CD4—multiple sclerosis	7.38e-06	0.000279	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ALB—multiple sclerosis	7.32e-06	0.000277	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ALB—multiple sclerosis	7.02e-06	0.000265	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—STAT3—multiple sclerosis	6.41e-06	0.000243	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MYC—multiple sclerosis	5.96e-06	0.000225	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TGFB1—multiple sclerosis	5.95e-06	0.000225	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MAPK1—multiple sclerosis	5.83e-06	0.000221	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—STAT3—multiple sclerosis	5.72e-06	0.000216	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MYC—multiple sclerosis	5.31e-06	0.000201	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TGFB1—multiple sclerosis	5.3e-06	0.0002	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MAPK1—multiple sclerosis	5.2e-06	0.000197	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—IL6—multiple sclerosis	4.48e-06	0.000169	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—IL6—multiple sclerosis	3.99e-06	0.000151	CbGpPWpGaD
